BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20592103)

  • 1. Plasma folate concentrations are positively associated with risk of estrogen receptor beta negative breast cancer in a Swedish nested case control study.
    Ericson U; Borgquist S; Ivarsson MI; Sonestedt E; Gullberg B; Carlson J; Olsson H; Jirström K; Wirfält E
    J Nutr; 2010 Sep; 140(9):1661-8. PubMed ID: 20592103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
    Sonestedt E; Borgquist S; Ericson U; Gullberg B; Olsson H; Adlercreutz H; Landberg G; Wirfält E
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3241-51. PubMed ID: 18990767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women.
    Lin J; Lee IM; Cook NR; Selhub J; Manson JE; Buring JE; Zhang SM
    Am J Clin Nutr; 2008 Mar; 87(3):734-43. PubMed ID: 18326613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma B-vitamin and one-carbon metabolites and risk of breast cancer before and after folic acid fortification in the United States.
    Houghton SC; Eliassen AH; Zhang SM; Selhub J; Rosner BA; Willett WC; Hankinson SE
    Int J Cancer; 2019 Apr; 144(8):1929-1940. PubMed ID: 30346061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study.
    Neuhouser ML; Cheng TY; Beresford SA; Brown E; Song X; Miller JW; Zheng Y; Thomson CA; Shikany JM; Vitolins MZ; Rohan T; Green R; Ulrich CM
    Int J Cancer; 2015 Aug; 137(4):930-9. PubMed ID: 25643945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of dietary folate, Vitamins B6 and B12 and methionine intake with risk of breast cancer among African American and European American women.
    Gong Z; Ambrosone CB; McCann SE; Zirpoli G; Chandran U; Hong CC; Bovbjerg DH; Jandorf L; Ciupak G; Pawlish K; Lu Q; Hwang H; Khoury T; Wiam B; Bandera EV
    Int J Cancer; 2014 Mar; 134(6):1422-35. PubMed ID: 23996837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma folate concentrations and colorectal cancer risk: a case-control study nested within the Shanghai Men's Health Study.
    Takata Y; Shrubsole MJ; Li H; Cai Q; Gao J; Wagner C; Wu J; Zheng W; Xiang YB; Shu XO
    Int J Cancer; 2014 Nov; 135(9):2191-8. PubMed ID: 24692023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
    Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer.
    Zhang SM; Willett WC; Selhub J; Hunter DJ; Giovannucci EL; Holmes MD; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2003 Mar; 95(5):373-80. PubMed ID: 12618502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for associations between common polymorphisms of estrogen receptor beta gene with homocysteine and nitric oxide.
    Reimann M; Vafeiadou K; Hall WL; Dierkes J; Nilsson M; Dahlman-Wright K; Ferrari M; Huebner U; Hallund J; Bugel S; Branca F; Williams CM; Koebnick C
    Climacteric; 2006 Jun; 9(3):215-23. PubMed ID: 16766435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
    Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmö Diet and Cancer cohort.
    Ericson U; Sonestedt E; Gullberg B; Olsson H; Wirfält E
    Am J Clin Nutr; 2007 Aug; 86(2):434-43. PubMed ID: 17684216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer.
    Wu K; Helzlsouer KJ; Comstock GW; Hoffman SC; Nadeau MR; Selhub J
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):209-17. PubMed ID: 10090298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk.
    Han J; Hankinson SE; Zhang SM; De Vivo I; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):520-4. PubMed ID: 15066914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma B-vitamins and one-carbon metabolites and the risk of breast cancer in younger women.
    Houghton SC; Eliassen AH; Zhang SM; Selhub J; Rosner BA; Willett WC; Hankinson SE
    Breast Cancer Res Treat; 2019 Jul; 176(1):191-203. PubMed ID: 30955184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Riboflavin and Vitamin B-6, but Not Homocysteine, Folate, or Vitamin B-12, Are Inversely Associated with Breast Cancer Risk in the European Prospective Investigation into Cancer and Nutrition-Varese Cohort.
    Agnoli C; Grioni S; Krogh V; Pala V; Allione A; Matullo G; Di Gaetano C; Tagliabue G; Pedraglio S; Garrone G; Cancarini I; Cavalleri A; Sieri S
    J Nutr; 2016 Jun; 146(6):1227-34. PubMed ID: 27121532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
    James RE; Lukanova A; Dossus L; Becker S; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Mesrine S; Engel P; Clavel-Chapelon F; Chang-Claude J; Vrieling A; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Rodríguez L; Buckland G; Sánchez MJ; Amiano P; Ardanaz E; Bueno-de-Mesquita B; Ros MM; van Gils CH; Peeters PH; Khaw KT; Wareham N; Key TJ; Allen NE; Romieu I; Siddiq A; Cox D; Riboli E; Kaaks R
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1626-35. PubMed ID: 21813404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
    Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.